Metraipolis › archive › dc_82440fb708fc

Phage endolysins as alternative antimicrobials: mechanisms, clinical progress, and emerging resistance frameworks — Europe PMC PMID:41953439

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41953439
DOI
10.3389/fmicb.2026.1762768
License (as archived)
solo-consultazione
Archived
2026-11-04T01:19:31.596Z
SHA-256 of the archived text
d5049775b32fdbc54c18b8cba07f6f22acda59bb2cda2cbb3600d6647cd85a89
Stable URL of this page
https://metraipolis.com/documento/dc_82440fb708fc

How to cite

Phage endolysins as alternative antimicrobials: mechanisms, clinical progress, and emerging resistance frameworks — Europe PMC PMID:41953439 — Europe PMC (en), https://europepmc.org/article/MED/41953439 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_82440fb708fc (Metraipolis archive dc_82440fb708fc, sha256 d5049775b32fdbc54c18b8cba07f6f22acda59bb2cda2cbb3600d6647cd85a89)
BibTeX
@misc{dc82440fb708fc,
  title = {Phage endolysins as alternative antimicrobials: mechanisms, clinical progress, and emerging resistance frameworks — Europe PMC PMID:41953439},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41953439},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_82440fb708fc; sha256 d5049775b32fdbc54c18b8cba07f6f22acda59bb2cda2cbb3600d6647cd85a89},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41953439. Agents can read the archived copy with the MCP tool read_document.